Persistent Asset Partners’s Biogen BIIB Stock Holding History

Persistent Asset Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,903	Closed	-$364K	–	824
2026 Q1	$349K	Sell	1,903 -971	-34%	-$179K	0.13%	138
2025 Q4	$506K	Buy	+2,874	New	+$470K	0.23%	126

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Persistent Asset Partners's BIIB Position: Q2 2026 in Review

Persistent Asset Partners sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1,903 shares — an estimated $364K sold.

Persistent Asset Partners first reported a position in BIIB in Q4 2025 and held it in 2 quarters. The position peaked at $506K in Q4 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Persistent Asset Partners reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
Persistent Asset Partners sold 1,903 Biogen shares in Q2 2026, an estimated $364K.
Persistent Asset Partners first reported a position in Biogen in Q4 2025 and held it in 2 quarters.
Persistent Asset Partners's Biogen position peaked at $506K in Q4 2025.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.